Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus

Sanjay Patel1, Ed Abrahamson2, Stephen Goldring3

  • 1Department of Paediatric Infectious Diseases & Immunology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK sanjay.patel@uhs.nhs.uk.

Insights

Managing children with intravenous antimicrobial therapy at home through paediatric outpatient parenteral antibiotic therapy (p-OPAT) services improves patient satisfaction and reduces healthcare-associated infections. These guidelines offer best practices for safe and effective p-OPAT delivery.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Health Services Research

Background:

  • Home-based intravenous antimicrobial therapy for children offers benefits like improved patient satisfaction, psychological well-being, and reduced healthcare costs.
  • Paediatric outpatient parenteral antibiotic therapy (p-OPAT) services are increasingly recognized for their potential to enhance care delivery.

Purpose of the Study:

  • To develop good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) services in the UK.
  • To provide a practical framework for the safe and effective implementation of p-OPAT in secondary and tertiary care settings.

Main Methods:

  • Joint development of guidelines by the BSAC and the British Paediatric Allergy, Immunity and Infection Group.
  • Comprehensive review of clinical practice, governance, patient selection, vascular access, antimicrobial management, and business case development for p-OPAT.

Main Results:

  • Established recommendations cover team roles, service structure, patient/pathology suitability, vascular access, antimicrobial choice, and clinical governance.
  • Guidance includes a process for developing a business case to support p-OPAT service implementation.

Conclusions:

  • Implementing robust p-OPAT services is crucial for optimizing paediatric antimicrobial therapy delivery.
  • These recommendations aim to ensure high standards of clinical practice and governance in UK p-OPAT services.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
808
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
377
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
962
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
918